CMDManagement
TM
Vol. 13, No. 2, Fall 2008 Pretest
Page One
Questions marked with an
*
are required.
1.
The ATP-III–recommended LDL-C goal for a patient with a
Framingham
risk score of 10% to 20% (10-year risk of coronary events) is which of the following?
<70 mg/dL
<100 mg/dL
<130 mg/dL
<160 mg/dL
2.
Which of the following factors influences the definition of “abnormal” carotid intima-media thickness (CIMT)?
Sex
Race
Weight
Both a and b
3.
Increased levels of high-sensitivity C-reactive protein (hs-CRP) are associated with a 2- to 3-fold increase in the prevalence of which of the following?
Peripheral arterial disease
Stroke
Myocardial infarction (MI)
All of the above
4.
According to data from the Multi-Ethnic Study of Atherosclerosis (MESA), CIMT was a better predictor of coronary heart disease (CHD) and total cardiovascular disease (CVD) events when compared with coronary artery calcium (CAC).
True
False
5.
Which of the following is true of FRS?
It predicts future “hard” CHD events (eg, MI, coronary death)
It predicts future “soft” CHD events (eg, angina, revascularization)
It is consistently accurate in predicting CVD risk among women with elevated baseline risk for CVD
Both a and b
6.
Which of the following components is included in Reynolds Risk Score determination but not in traditional
Framingham
risk scoring?
Smoking status
hs-CRP
Family history of CHD
Both a and b
Both b and c
7.
According to American Heart Association/American College of Cardiology (AHA/ACC) guidelines for CVD prevention in women, which of the following criteria is NOT exhibited by women in the “at-risk” category?
Obesity
FRS <10%
Poor diet
Evidence of subclinical vascular disease
8.
“High-risk” women should be treated aggressively with AHA/ACC-recommended secondary preventive pharmacologic therapies including aspirin and a statin (for optional goal of LDL-C <70 mg/dL).
True
False
9.
Please enter your email address. In 6 weeks, we'll be sending you an email containing a link to a follow-up posttest.
Online Surveys
powered by SurveyGizmo
